Inventor · disambiguated record
Daisuke Okajima
Also filed as: OKAJIMA DAISUKE
11 granted patents·10 pending applications·102 citations·filing 2006–2025
88Inventor score
Top patents by PatentIndex Score
21 records- 0196US9850312B2Anti-TROP2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Dec 26, 2017·64 cites·14 claims
- 0295US10227417B2Anti-TROP2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2017·Granted Mar 12, 2019·27 cites·16 claims
- 0390US12246196B2Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepinesDAIICHI SANKYO CO LTD·Filed 2022·Granted Mar 11, 2025·1 cites·34 claims
- 0489US11583590B2Antibody-pyrrolobenzodiazepine derivative conjugate and method of use thereof for treating a tumorDAIICHI SANKYO CO LTD·Filed 2021·Granted Feb 21, 2023·1 cites·30 claims
- 0584US11008398B2Anti-TROP2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2019·Granted May 18, 2021·3 cites·8 claims
- 0684US2025114647A1ANTIBODY-DRUG CONJUGATES COMPRISING SUBSTITUTED BENZO[e]PYRROLO[1,2-a][1,4]DIAZEPINESDAIICHI SANKYO COMPANY LIMTED·Filed 2024·Application pending·0 cites
- 0783US11628223B2Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-α][1,4]diazepinesDAIICHI SANKYO CO LTD·Filed 2018·Granted Apr 18, 2023·1 cites·1 claims
- 0882US11173213B2Method for selectively manufacturing antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Nov 16, 2021·3 cites·26 claims
- 0978US12350344B2Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugateDAIICHI SANKYO CO LTD·Filed 2022·Granted Jul 8, 2025·0 cites·36 claims
- 1076US2025257146A1Anti-trop2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2025·Application pending·0 cites
- 1174US7527937B2Assay employing a g-protein coupled receptor that is activated by CCK-8SDAIICHI SANKYO CO LTD·Filed 2006·Granted May 5, 2009·2 cites·10 claims
- 1272US2021238303A1Anti-trop2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2021·Application pending·0 cites
- 1361US2021386865A1Method for selectively manufacturing antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2021·Application pending·0 cites
- 1458US7977069B2DNA encoding a CCK-8S G-protein coupled receptor, and vectors, transformants, cell kits, and methods employing such DNADAIICHI SANKYO CO LTD·Filed 2009·Granted Jul 12, 2011·0 cites·9 claims
- 1556US2025288687A1Combination of antibody-drug conjugates and dnmt inhibitorsDAIICHI SANKYO CO LTD·Filed 2025·Application pending·0 cites
- 1655US2022023436A1Combination of antibody-drug conjugate with parp inhibitorDAIICHI SANKYO CO LTD·Filed 2019·Application pending·0 cites
- 1752US2010029702A1Method For Identification of Compound Having Anti-Anxiety EffectOKAJIMA DAISUKE·Filed 2007·Application pending·0 cites
- 1852US2011223175A1Gene Encoding G-Protein Coupled Receptor And Gene Product ThereofDAIICHI SANKYO CO LTD·Filed 2011·Application pending·0 cites
- 1951US2022040324A1Combination of antibody-drug conjugate and kinase inhibitorDAIICHI SANKYO CO LTD·Filed 2019·Application pending·0 cites
- 2045US2023270870A1Dosage of an antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Application pending·0 cites
- 2144US12312641B2Sensitivity marker for antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2019·Granted May 27, 2025·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Daisuke Okajima files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →